comparemela.com

Latest Breaking News On - Rocket pharmaceuticals stock performance - Page 1 : comparemela.com

Avoro Capital Advisors LLC Increases Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)

Avoro Capital Advisors LLC increased its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 0.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,260,900 shares of the biotechnology company’s stock after buying an additional 10,900 shares during the quarter. […]

New-york
United-states
William-blair
Gaurav-shah
John-militello
News-ratings-for-rocket-pharmaceuticals-daily
Avoro-capital-advisors
Principal-financial-group-inc
Nasdaq
Rocket-pharmaceuticals
Rocket-pharmaceuticals-inc
Jpmorgan-chase-co

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have received a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price […]

Texas
United-states
John-militello
Mark-andrew-white
Rocket-pharmaceuticals-inc
Allspring-global-investments-holdings
Torray-investment-partners
Rocket-pharmaceuticals-company-profile
Nasdaq
Analyst-recommendations-for-rocket-pharmaceuticals
Jpmorgan-chase-co
News-ratings-for-rocket-pharmaceuticals-daily

John Militello Sells 1,079 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Stock

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) insider John Militello sold 1,079 shares of the company’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $23.35, for a total transaction of $25,194.65. Following the completion of the sale, the insider now owns 53,327 shares of the […]

Wellington
New-zealand-general
New-zealand
John-militello
Wellington-management-group
News-ratings-for-rocket-pharmaceuticals-daily
Rocket-pharmaceuticals
Pricet-rowe-associates-inc
Goldman-sachs-group
Nasdaq
Rocket-pharmaceuticals-inc
Quarter-for-rocket-pharmaceuticals

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) General Counsel Martin Wilson Sells 1,048 Shares

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) General Counsel Martin Wilson sold 1,048 shares of Rocket Pharmaceuticals stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $23.35, for a total transaction of $24,470.80. Following the completion of the transaction, the general counsel now directly owns 65,762 […]

Texas
United-states
America
Zurcher-kantonalbank-zurich-cantonalbank
Martin-wilson
Cantor-fitzgerald
Jpmorgan-chase-co
Needham-company
Asset-management-north-america-corp
Rocket-pharmaceuticals-stock-performance
York-mellon-corp
Allspring-global-investments-holdings

Rocket Pharmaceuticals (NASDAQ:RCKT) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Rocket Pharmaceuticals (NASDAQ:RCKT) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Kinnari-patel
Davidp-southwell
Rocket-pharmaceuticals-inc
News-ratings-for-rocket-pharmaceuticals-daily
Jpmorgan-chase-co
Goldman-sachs-group
Securities-exchange-commission
Rocket-pharmaceuticals
Earnings-history-for-rocket-pharmaceuticals
Cantor-fitzgerald
Rocket-pharmaceuticals-stock-performance
Rocket-pharmaceuticals-company-profile
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.